This study was designed to: (1) determine plasma midazolam concentrations producing adequate sedation in ICU patients; (2) establish an intravenous regimen to provide continuous sedation and rapid recovery after discontinuation of infusion. Initially, 13 ICU patients were given midazolam as a bolus
Midazolam infusion and the benzodiazepine antagonist flumazenil for sedation of intensive care patients
β Scribed by E. Geller; P. Halpern; E. Barzelai; P. Sorkine; M.C. Lewis; A. Silbiger; Y. Nevo
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 641 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0300-9572
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract BACKGROUND: Dexmedetomidine is a potentially useful sedative for hospitalized children, but there is little published data regarding its safety, dosage, or efficacy. OBJECTIVE: To report our experience with dexmedetomidine for the sedation of hospitalized children. DESIGN: Retrospe
Dexmedetomidine, a highly selective and potent Ξ±~2~βadrenergic agonist, has a potentially useful role as a sedative agent in patients requiring intensive care. As part of a larger European multicentre trial, a total of 119 postoperative cardiac and general surgical patients requiring ventilation and
Patients with impending or established single or multiple organ system failure are described as critically ill. Patient outcomes are optimized by skilled nursing units led by physicians trained in critical care medicineintensivists. The impetus for subspecialization in the practice of critical care
## Abstract ## BACKGROUND The objective of the current study was to determine the association of age, comorbid illness, and length of stay (LOS) in the intensive care unit (ICU) in women who underwent oophorectomy for ovarian carcinoma. ## METHODS The authors conducted a populationβbased analysi